SERGEI BELKIN: Open Payments
NPI 1083609762 · GLEN COVE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 38 payments from 10 companies in 2025. Trend: 2023 $1,350 · 2024 $1,331 · 2025 $1,805
Food & beverage: $1,805
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $650 |
| Alkermes, Inc. | 5 | $395 |
| Lundbeck LLC | 10 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $122 |
| Neurocrine BioSciences, Inc. | 1 | $118 |
| Otsuka America Pharmaceutical, Inc. | 1 | $117 |
| E.R. Squibb & Sons, L.L.C. | 1 | $113 |
| Tris Pharma Inc | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
Products named: Auvelity, REXULTI, LYBALVI, ARISTADA, CAPLYTA, INGREZZA, COBENFY, Dyanavel XR.
Industry payments across NY — which companies pay providers there.
